Nr 546 week 5 table Study guides, Class notes & Summaries

Presentation NR 546 Week 2 Assignment; Neurotransmitter Table 2022 * To be completed throughout course and submitted in Week 8* Neuro transmitter Receptor Subtype Location/Function/Effects /symptoms of excess or deficit if applicable Distribution (ie: CNS/PNS, GI, vascular) Drug classes that target this neurotransmitter or receptor Specific medications that target this neurotransmitter or receptor Glutamate AMPA α-Amino-3-hydroxy-5- methyl-4- isoxazolepropionic acid (AMPA)-type glutamat...

NR 546 Week 7 ADHD Medication Table / NR 546 Week 7 ADHD Medication Table Latest UPDATE 2024 GRADED A+. Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediate-acting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) Indication (include approved ages) Attention deficit hyperactivity disord...

Presentation NR 546 Week 2 Assignment; Neurotransmitter Table 2022 * To be completed throughout course and submitted in Week 8* Neuro transmitter Receptor Subtype Location/Function/Effects /symptoms of excess or deficit if applicable Distribution (ie: CNS/PNS, GI, vascular) Drug classes that target this neurotransmitter or receptor Specific medications that target this neurotransmitter or receptor Glutamate AMPA α-Amino-3-hydroxy-5- methyl-4- isoxazolepropionic acid (AMPA)-type glutamat...

NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table.

NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table latest update 2024 GRADED A+ Antidepressant Medications Name Indication, starting dose, target symptoms, and affected neurotransmitters Half-life (T1/2) CYP450 enzyme Notes/Notable side effects/Precautions SSRIs Citalopram (Celexa) Selective serotonin reuptake inhibitor Commonly prescribed for depression, PMDD, OCD, panic disorder, GAD, PTSD, social anxiety disorder Starting dose: 20mg/day Blocks ser...

Presentation NR 546 Week 2 Assignment; Neurotransmitter Table 2022 * To be completed throughout course and submitted in Week 8* Neuro transmitter Receptor Subtype Location/Function/Effects /symptoms of excess or deficit if applicable Distribution (ie: CNS/PNS, GI, vascular) Drug classes that target this neurotransmitter or receptor Specific medications that target this neurotransmitter or receptor Glutamate AMPA α-Amino-3-hydroxy-5- methyl-4- isoxazolepropionic acid (AMPA)-type glutamat...

NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table latest update 2024 GRADED A+

Presentation NR 546 Week 2 Assignment; Neurotransmitter Table 2022 * To be completed throughout course and submitted in Week 8* Neuro transmitter Receptor Subtype Location/Function/Effects /symptoms of excess or deficit if applicable Distribution (ie: CNS/PNS, GI, vascular) Drug classes that target this neurotransmitter or receptor Specific medications that target this neurotransmitter or receptor Glutamate AMPA α-Amino-3-hydroxy-5- methyl-4- isoxazolepropionic acid (AMPA)-type glutamat...

NR 546 Midterm Exam Study Guide Midterm Exam Review the weekly Explore section content and required readings as noted within your Student Lesson Plan for Learning Success. Review the Tables you have completed. Each week will 17-18 questions. Week 1 Functional neuroanatomy- brain anatomy and physiology covered in both the course Explore section and readings. If a particular area of the brain is affected, what is the expected response? What symptoms would you expect to see? Link the a...

NR 546 WEEK 7 ADHD Medication Table. Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediateacting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) -Dopamine, norepinephrine inhibitor and releaser (DNRIRe), stimulant, FDA approved for ADHD in children and adults (ages vary based on formulatio...